These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20825255)

  • 1. Addressing recent concerns in comparative studies of botulinum toxin type A.
    de Boulle K; de Almeida AT
    J Cosmet Laser Ther; 2010 Oct; 12(5):246-8. PubMed ID: 20825255
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introduction. Botulinum toxin].
    Beylot C; Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S53-4. PubMed ID: 19576485
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in botulinum toxins: time to end the confusion.
    Brin MF; Tan K; Gallagher C
    J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521
    [No Abstract]   [Full Text] [Related]  

  • 6. Information from your family doctor. Cosmetic botulinum toxin injection.
    Am Fam Physician; 2014 Aug; 90(3):Online. PubMed ID: 25077726
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin in aesthetic applications: 'how often misused words generate misleading thoughts'. (Response to: De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87-92).
    Pickett A; Rzany B
    J Cosmet Laser Ther; 2009 Sep; 11(3):178-9; author reply 180-1. PubMed ID: 19337943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Declaration of the principles for the administration of botulinum toxin].
    Plast Reconstr Surg; 2004 Oct; 114(5 Suppl):5S-6S. PubMed ID: 15722912
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of botulinum toxins: past, present, and future.
    Cartee TV; Monheit GD
    Clin Plast Surg; 2011 Jul; 38(3):409-26, vi. PubMed ID: 21824539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin: clinical techniques, applications, and complications.
    Stephan S; Wang TD
    Facial Plast Surg; 2011 Dec; 27(6):529-39. PubMed ID: 22205526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
    Beer KR; Wilson F
    Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compositional differences among commercially available botulinum toxin type A.
    Bakshi E; Hartstein ME
    Curr Opin Ophthalmol; 2011 Sep; 22(5):407-12. PubMed ID: 21825992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of botulinum neurotoxins.
    Lowe NJ
    J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
    Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
    Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
    Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.